AGRYLIN®

AGRYLIN® is a brand-name medication containing anagrelide hydrochloride, used to treat a specific blood disorder known as essential thrombocythemia. It is classified as a platelet-reducing agent and plays a crucial role in reducing the risk of thrombotic and hemorrhagic complications associated with this condition.

Indications and Uses 

AGRYLIN® is indicated for the following purposes:

• Treatment of elevated platelet counts (thrombocytosis) in individuals with essential thrombocythemia.

• Reducing the risk of thrombotic or hemorrhagic complications in these patients.

Dosage and Administration:

The dosage and administration of AGRYLIN® are determined by a healthcare provider and may vary based on the patient's specific platelet count and response to treatment. Typically administered orally, as capsules, with or without food. It is essential to follow the prescribed dosage and instructions carefully.

Contraindications

AGRYLIN® should not be used in individuals with a known hypersensitivity to anagrelide or any of its components.

Adverse Effects and Side Effects

Common side effects of AGRYLIN® may include:

• Headache.

• Dizziness.

• Nausea.

• Diarrhea.

• Abdominal pain.

• Edema (swelling).

• Palpitations.

Serious side effects are less common but may include:

• Cardiovascular effects, such as arrhythmias (irregular heartbeats) and heart problems.

• Hematologic effects, including decreased platelet count and potential bleeding disorders.

• Liver enzyme abnormalities, which may necessitate monitoring during treatment.

• It is essential to report any side effects, especially serious or unexpected ones, to your healthcare provider.

Storage and Shelf Life:

Store AGRYLIN® at room temperature, preferably between 15-30°C (59-86°F). Protect the medication from excessive heat, moisture, and direct light. Do not use AGRYLIN® after the expiration date.

Packaging and Presentation 

AGRYLIN® is typically available in capsule form, and it is supplied in blister packs or bottles, each containing a specific quantity of capsules.

Regulatory Information

AGRYLIN® is regulated by health authorities and complies with quality control standards to ensure its safety and efficacy. It is essential to use AGRYLIN® as directed by a healthcare professional and in accordance with local regulations.

References

Always consult with your healthcare provider and refer to the official prescribing information and product labeling for the most up-to-date and comprehensive information on AGRYLIN®. Your healthcare provider will guide you in the proper use of this medication, monitor your progress, and tailor the treatment to your specific medical condition.